Cargando…

Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents

BACKGROUND: To report the switch rate of conventional immunosuppressive (CIS) therapies to the biological agents (BA) in patients with refractory Behcet’s uveitis (BU). METHODS: In this retrospective study, clinical records were reviewed of 76 patients’ 116 eyes presenting with BU who had been treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Celiker, Hande, Kazokoglu, Haluk, Direskeneli, Haner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173844/ https://www.ncbi.nlm.nih.gov/pubmed/30290779 http://dx.doi.org/10.1186/s12886-018-0929-5

Ejemplares similares

Biologic treatments in Behçet's disease
por: Alibaz-Öner, Fatma, et al.
Publicado: (2022)

Advances in the Treatment of Behcet’s Disease
por: Alibaz-Oner, Fatma, et al.
Publicado: (2021)

Update on the Diagnosis of Behçet’s Disease
por: Alibaz-Oner, Fatma, et al.
Publicado: (2022)

Cytomegalovirus Retinitis in an ALL Child during Maintenance Therapy Treated Successfully with Intravenous Ganciclovir
por: Celiker, Hande, et al.
Publicado: (2014)

Pathogenesis of Behçet's Syndrome: Genetic, Environmental and Immunological Factors
por: Mattioli, Irene, et al.
Publicado: (2021)

Immune Reactions in Behçet's Disease
por: Kaneko, Fumio, et al.
Publicado: (2014)

Decreasing incidence and severity of Behçet’s disease: a changing trend in epidemiological spectrum possibly associated with oral health
por: MUMCU, Gonca, et al.
Publicado: (2020)

Expression of regulatory receptors on γδ T Cells and their cytokine production in Behcet's disease
por: Parlakgul, Gunes, et al.
Publicado: (2013)

Behçet's Uveitis
por: Tugal-Tutkun, Ilknur
Publicado: (2009)

Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study
por: Fei, Yiping, et al.
Publicado: (2009)

Behçet’s Disease Uveitis
por: Joubert, Morgane, et al.
Publicado: (2023)

Granulomatous anterior uveitis following mRNA-based COVID-19 vaccination: A case report
por: Cam, Furkan, et al.
Publicado: (2023)

Macular involvement in patients with Behçet’s uveitis
por: Kahloun, Rim, et al.
Publicado: (2012)

Vitreomacular Interface Disorders in Behçet’s Uveitis
por: Eser Öztürk, Hilal, et al.
Publicado: (2017)

Successful treatment of Behçet’s uveitis with Tocilizumab
por: Alokaily, F., et al.
Publicado: (2017)

An update on the use of biologic therapies in the management of uveitis in Behçet’s disease: a comprehensive review
por: McNally, Thomas W., et al.
Publicado: (2017)

The assessment of contributing factors to oral ulcer presence in Behçet’s disease: Dietary and non-dietary factors
por: İris, Merve, et al.
Publicado: (2018)

Behçet's disease: from innate to adaptive immunity
por: Direskeneli, H
Publicado: (2003)

Gender Differences in Behçet's Disease Associated Uveitis
por: Ucar-Comlekoglu, Didar, et al.
Publicado: (2014)

Behçet’s Uveitis: Current Diagnostic and Therapeutic Approach
por: Çakar Özdal, Pınar
Publicado: (2020)

Behçet uveitis: Current practice and future perspectives
por: Aboul Naga, Shereen H., et al.
Publicado: (2022)

How challenging can it be to treat Behçet uveitis?
por: Oray, Merih, et al.
Publicado: (2022)

Commentary: Behçet’s uveitis – Expanding treatment horizons
por: Moreker, Mayur R
Publicado: (2023)

Clinical profile and management with immunosuppressants and biologics in Behcet’s uveitis: A cohort of 25 patients from a tertiary eye care center in South India
por: Ramdoss, Jeyasooriya, et al.
Publicado: (2023)

Comparison of Sociodemographic Features Between Behçet Uveitis and Other Non-infectious Uveitis
por: Yalçındağ, F. Nilüfer, et al.
Publicado: (2021)

New Immunosuppressive Therapies in Uveitis Treatment
por: Mérida, Salvador, et al.
Publicado: (2015)

Anti-tumour necrosis factor-alpha agent therapy, compared with conventional therapy, reduces the relapse of uveitis in patients with behçet’s disease: A systematic review of controlled trials
por: Zhou, Xinwei, et al.
Publicado: (2022)

A Review of Systemic Biologics and Local Immunosuppressive Medications in Uveitis
por: S. Mehta, Neesurg, et al.
Publicado: (2022)

Innate and Adaptive Responses to Heat Shock Proteins in Behcet's Disease
por: Direskeneli, H.
Publicado: (2013)

Shaping the Future of Behçet’s Uveitis Management: A Comprehensive Review of Efficacy, Challenges, and Prospects of Biologic Therapies
por: Li, Biao, et al.
Publicado: (2023)

P03-009 - Experiences of in pediatric Behçet uveitis
por: Sozeri, B, et al.
Publicado: (2013)

Pattern of Uveitis Associated with Behçet’s Disease in an Egyptian Cohort
por: Abd El Latif, Eiman, et al.
Publicado: (2020)

Old and New Challenges in Uveitis Associated with Behçet’s Disease
por: Gueudry, Julie, et al.
Publicado: (2021)

Targeted resequencing of candidate genes reveals novel variants associated with severe Behçet's uveitis
por: Kim, Sang Jin, et al.
Publicado: (2013)

Treatment in Latent Tuberculosis Uveitis—Is Immunosuppression Effective or Is Conventional 3- or 4-Drug Antituberculosis Therapy Mandatory?
por: Bigdon, Eileen, et al.
Publicado: (2022)

Systemic immunosuppressive therapies for uveitis in developing countries
por: Agrawal, Hitesh, et al.
Publicado: (2020)

Comparison of Efficacy and Side Effects of Multispot Lasers and Conventional Lasers for Diabetic Retinopathy Treatment
por: Çeliker, Hande, et al.
Publicado: (2017)

Aortitis and uveitis. A challenging case of Takayasu or Behcet disease?
por: Di Landro, Giancarla, et al.
Publicado: (2014)

Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
por: Hiyama, Tomona, et al.
Publicado: (2019)

Pattern and Visual Prognostic Factors of Behcet’s Uveitis in Northwest Iran
por: Alizadeh Ghavidel, Leila, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gparroq813c15krtjc12lhr9dh